NASDAQ · Drug Manufacturers - Specialty & Generic

China SXT Pharmaceuticals, Inc. (SXTC) Stock

$0.15 -56.71% NASDAQ: SXTC Healthcare

Valuation

MetricValue
Price$0.15
Market Cap$79402
P/E Ratio-0.28
P/B Ratio0.05
P/S Ratio0.51
EPS (TTM)$-8.18
52-Week High$83760.00
52-Week Low$0.14
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-31.02%
ROA-21.22%
ROCE-28.07%
Gross Margin-100.00%
Operating Margin-150.00%
Net Margin-290.71%
Debt/Equity0.04
Current Ratio3.50

Annual Financials (USD)

Metric20222023202420252026
Revenue$3.0M$2.0M$2.0M$2.0M$1.0M
Operating Profit$-5.0M$-6.0M$-3.0M$-3.0M$-7.0M
Net Profit$-6.0M$-6.0M$-3.0M$-3.0M$-6.0M
EPS$-137.92$-22.23$-3.57$-8.18$-9.13
Op Margin-199.4%-284.4%-130.4%-154.0%-664.1%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$34.0M$30.0M$23.0M$22.0M$35.0M
Total Liabilities$17.0M$15.0M$9.0M$6.0M$5.0M
Cash$16.0M$17.0M$12.0M$18.0M$28.0M
Borrowings$11.0M$4.0M$3.0M$1.0M$1.0M

Latest News

China Sxt Pharmaceuticals Files Resale Registration for Up to 157.5 Million Shares MT Newswires · Jul 7, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-2.0M$0$-2.0M$-2.0M$-4.0M
Investing Cash Flow$0$0$0$0$-1.0M
Financing Cash Flow$2.0M$-3.0M$-4.0M$6.0M$0
Net Cash Flow$0$2.0M$-5.0M$6.0M$10.0M
Free Cash Flow$-2.0M$0$-2.0M$-2.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA3.08
FCF Yield-400.19%
Quick Ratio7.25
Interest Coverage-27.39
Return 1Y-98.97%
Return 3Y-99.65%
Return 5Y-99.97%

Ownership

Insiders Held109.48%
Institutions Held0.24%
Institutions Float Held-2.56%
Institutional HolderSharesReport Date
Sabby Management, LLC78,1702026-03-31
UBS Group AG12026-03-31
Caitong International Asset Management Co., Ltd12026-03-31
Royal Bank of Canada132026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc. is led by CEO Feng Zhou, publicly traded since 2019.

China SXT Pharmaceuticals, Inc. (SXTC) stock trades at $0.15 with a market capitalization of $79402. The stock is valued at a price-to-earnings (P/E) ratio of -0.28, price-to-book of 0.05, price-to-sales of 0.51. Over the past 52 weeks the stock has ranged between $0.14 and $83760.00, and currently trades 100.0% below its 52-week high.

On profitability, China SXT Pharmaceuticals, Inc. generates a return on equity (ROE) of -31.02%, return on capital employed of -28.07%, an operating margin of -150.00%, a net profit margin of -290.71%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides